Erez is a modern, hybrid-indica strain whose genetic lineage remains undocumented. There is no publicly confirmed breeding history or official record detailing the crossing that produced this cultivar, making its origins a mystery within the contemporary landscape. Growers typically find the strain to be of moderate cultivation difficulty, successfully producing high yields within an indoor or outdoor environment over a 60-day flowering period.

The chemical expression of Erez is defined by a complex, confirmed terpene profile. Caryophyllene serves as the dominant terpene, followed by myrcene, limonene, pinene, humulene, ocimene, nerolidol, linalool, beta-pinene, guaiol, p-cymene, bisabolol, eucalyptol, camphene, and caryophyllene-oxide. Regarding potency, the strain features an estimated THC concentration of approximately 18.2%, with an estimated CBD and CBG content of 0% each. This specific chemical convergence creates a distinct aromatic profile rooted in this documented sequence of secondary metabolites.

The reported effects of Erez are characterized by a sense of relaxation and focus, making it a functional choice for those managing pain, stress, or sleep difficulties. As an indica-leaning hybrid with a balanced focus on relief and mental clarity, it serves specific therapeutic applications without a recorded history of notable offspring. The plant remains an enigmatic entry in the modern catalogue, prioritized for its practical performance in the garden and its documented, multifaceted terpene array.